A white paper from ERS Genomics
This white paper from ERS Genomics describes how CRISPR-Cas9 antimicrobials are being investigated to combat antibiotic resistance by inducing bacterial cell death, suppressing growth, deleting functional genes from pathogens, or altering mobile elements responsible for transferring resistance genes.
Offered Free by: ERS Genomics
See All Resources from: ERS Genomics
This download should complete shortly. If the resource doesn't automatically download, please, click here.